Mortality risk factors of a pediatric population with fulminant hepatic failure undergoing orthotopic liver transplantation in a pediatric intensive care unit*
- 1 July 2002
- journal article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 3 (3) , 227-233
- https://doi.org/10.1097/00130478-200207000-00004
Abstract
OBJECTIVES: To determine risk factors of mortality in the preoperative, perioperative, and immediate postoperative period of a pediatric population that has undergone orthotopic liver transplantation for fulminant hepatic failure in a pediatric intensive care unit. DESIGN: Retrospective review of medical records. SETTING: A pediatric intensive care unit in a children's hospital. PATIENTS: Sixty patients with fulminant hepatic failure who fulfilled King's College criteria for liver transplantation. INTERVENTION: Orthotopic liver transplantation was performed according to standard techniques. Before transplantation, patients were admitted to a pediatric intensive care unit when intensive care was required, and patients were always admitted to a pediatric intensive care unit after the operation. Measurements: A total of 20 variables were studied via univariate and multivariate analysis; statistical significance was accepted when p </=.05. MAIN RESULTS: A total of 70 orthotopic liver transplantations were performed in 60 children (mean age, 64.11 +/- 40.97 months; range, 11 months to 14 yrs) for fulminant hepatic failure. Fulminant hepatic failure was caused by hepatitis A virus in 60% of cases, and non-A non-B non-C hepatitis was responsible in 40% of cases. Univariate analysis showed that the complications of infectious, hemodynamic, renal, and gastrointestinal bleeding are significant variables. Posttransplant respiratory support was also a significant variable. When the same variables were calculated with a multivariate analysis, no significant results were obtained. Multivariate analysis showed that mortality risk factors in this population were: etiology of liver failure (p <.002), liver size (p <.014), ischemia time (p <.041), ventilatory support before transplantation (p <.048), neurologic complications after orthotopic liver transplantation (p <.003), and acute rejection (p <.021). CONCLUSIONS: Hepatitis A virus is the major cause of fulminant liver failure in Argentina, but non-A non-B non-C hepatitis is an independent risk factor of mortality. Reduced-size graft, longer ischemia time, ventilatory support before orthotopic liver transplantation, neurologic complications, and acute rejection after transplantation are independent predictive factors of mortality. Better sanitary conditions and universal immunization for hepatitis A virus should reduce hepatitis A virus and hepatitis A virus-induced fulminant hepatic failure.Keywords
This publication has 20 references indexed in Scilit:
- Clinical course and consequences of hepatitis A infectionVaccine, 2000
- Etiology and outcome for 295 patients with acute liver failure in the united statesLiver Transplantation and Surgery, 1999
- Banff Schema for Grading Liver Allograft Rejection: An International Consensus DocumentHepatology, 1997
- Classification, Etiology, and Considerations of Outcome in Acute Liver FailureSeminars in Liver Disease, 1996
- Fulminant Hepatic Failure: Pediatric AspectsSeminars in Liver Disease, 1996
- Orthotopic Liver Transplantation with Preservation of the Inferior Vena CavaAnnals of Surgery, 1989
- Early indicators of prognosis in fulminant hepatic failureGastroenterology, 1989
- Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failureGastroenterology, 1988
- Fulminant and Subfulminant Liver Failure: Definitions and CausesSeminars in Liver Disease, 1986
- Refinements in the Surgical Technique of Liver TransplantationSeminars in Liver Disease, 1985